Meds Apotek AB (STO:MEDS)
26.00
-1.10 (-4.06%)
At close: Apr 13, 2026
Meds Apotek AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 45.17 | 21.17 | 50.59 | 24.74 | 78.85 |
Cash & Short-Term Investments | 45.17 | 21.17 | 50.59 | 24.74 | 78.85 |
Cash Growth | 113.38% | -58.16% | 104.48% | -68.63% | 222.29% |
Accounts Receivable | 25.76 | 24.01 | 14.95 | 14.67 | 13.7 |
Other Receivables | 9.95 | 5.96 | 2.68 | 5.21 | 3.8 |
Receivables | 35.71 | 29.97 | 17.64 | 19.88 | 17.5 |
Inventory | 144.17 | 102.27 | 81.76 | 66.64 | 61.41 |
Prepaid Expenses | 4.48 | 3.47 | 1.41 | - | - |
Other Current Assets | -0 | - | -0 | - | - |
Total Current Assets | 229.53 | 156.88 | 151.39 | 111.26 | 157.76 |
Property, Plant & Equipment | 17.65 | 36.1 | 46.49 | 54.7 | 49.66 |
Long-Term Investments | 0.79 | 0.43 | 0.13 | 0.18 | 0.03 |
Other Intangible Assets | 12.27 | 14.55 | 18.07 | 20.11 | 10.99 |
Long-Term Deferred Tax Assets | 10.46 | 0.2 | 0.22 | - | - |
Other Long-Term Assets | - | - | - | 0 | -0 |
Total Assets | 270.7 | 208.16 | 216.31 | 186.25 | 218.44 |
Accounts Payable | 114.11 | 103.84 | 58.41 | 65.44 | 67.01 |
Accrued Expenses | 17.09 | 18.52 | 15.1 | - | - |
Current Portion of Long-Term Debt | - | - | 6.41 | - | - |
Current Portion of Leases | 7.05 | 8.37 | 9.76 | - | - |
Current Unearned Revenue | - | - | 1.64 | - | - |
Other Current Liabilities | 2.41 | 1.47 | 5.87 | 25.07 | 25.62 |
Total Current Liabilities | 140.66 | 132.2 | 97.19 | 90.51 | 92.62 |
Long-Term Debt | - | - | 23.33 | - | - |
Long-Term Leases | - | 15.72 | 25.41 | - | - |
Long-Term Deferred Tax Liabilities | 0.67 | 1.14 | 1.87 | - | - |
Other Long-Term Liabilities | 0.98 | 0.43 | 0.13 | 33.43 | 34.49 |
Total Liabilities | 142.31 | 149.48 | 147.93 | 123.94 | 127.11 |
Common Stock | 0.74 | 0.69 | 0.69 | 0.63 | 0.33 |
Additional Paid-In Capital | 609.84 | 547.91 | 546.62 | - | - |
Retained Earnings | -482.19 | -489.91 | -478.92 | -109.51 | -317.93 |
Comprehensive Income & Other | -0 | -0 | 0 | 171.19 | 408.93 |
Shareholders' Equity | 128.4 | 58.68 | 68.39 | 62.31 | 91.33 |
Total Liabilities & Equity | 270.7 | 208.16 | 216.31 | 186.25 | 218.44 |
Total Debt | 7.05 | 24.08 | 64.91 | - | - |
Net Cash (Debt) | 38.12 | -2.92 | -14.33 | - | - |
Net Cash Per Share | 2.14 | -0.17 | -0.86 | - | - |
Filing Date Shares Outstanding | 18.57 | 17.25 | 16.75 | - | - |
Total Common Shares Outstanding | 18.57 | 17.25 | 16.75 | - | - |
Working Capital | 88.88 | 24.68 | 54.21 | - | - |
Book Value Per Share | 6.91 | 3.40 | 4.08 | - | - |
Tangible Book Value | 116.13 | 44.13 | 50.32 | - | - |
Tangible Book Value Per Share | 6.25 | 2.56 | 3.00 | - | - |
Machinery | 18.58 | 17.98 | 17.53 | 54.7 | 49.66 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.